|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Šarenac T and Mikov M: Cervical cancer, different treatments and importance of bile acids as therapeutic agents in this disease. Front Pharmacol. 10:4842019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang L, Wu J, Ling MT, Zhao L and Zhao KN: The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses. Mol Cancer. 14:872015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim TJ, Lee JW, Song SY, Choi JJ, Choi CH, Kim BG, Lee JH and Bae DS: Increased expression of pAKT is associated with radiation resistance in cervical cancer. Br J Cancer. 94:1678–1682. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Balasuriya N, McKenna M, Liu X, Li SS and O'Donoghue P: Phosphorylation-dependent inhibition of Akt1. Genes (Basel). 9:4502018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Manning BD and Toker A: AKT/PKB signaling: Navigating the network. Cell. 169:381–405. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shi X, Ran L, Liu Y, Zhong SH, Zhou PP, Liao MX and Fang W: Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway. Oncol Rep. 39:939–950. 2018.PubMed/NCBI
|
|
8
|
Manning BD and Cantley LC: AKT/PKB signaling: Navigating downstream. Cell. 129:1261–1274. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhuang J, Hawkins SF, Glenn MA, Lin K, Johnson GG, Carter A, Cawley JC and Pettitt AR: Akt is activated in chronic lymphocytic leukemia cells and delivers a pro-survival signal: The therapeutic potential of Akt inhibition. Haematologica. 95:110–118. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Karimian A, Ahmadi Y and Yousefi B: Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage. DNA Repair (Amst). 42:63–71. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu J, Li Q, Liu Z, Lin L, Zhang X, Cao M and Jiang J: Harmine induces cell cycle arrest and mitochondrial pathway-mediated cellular apoptosis in SW620 cells via inhibition of the Akt and ERK signaling pathways. Oncol Rep. 35:3363–3370. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Behan FM, Iorio F, Picco G, Gonçalves E, Beaver CM, Migliardi G, Santos R, Rao Y, Sassi F, Pinnelli M, et al: Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens. Nature. 568:511–516. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sharma BR, Gautam LN, Adhikari D and Karki R: A comprehensive review on chemical profiling of nelumbo nucifera: Potential for drug development. Phytother Res. 31:3–26. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shen CY, Jiang JG, Yang L, Wang DW and Zhu W: Anti-ageing active ingredients from herbs and nutraceuticals used in traditional Chinese medicine: Pharmacological mechanisms and implications for drug discovery. Br J Pharmacol. 174:1395–1425. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Manogaran P, Beeraka NM, Huang CY and Vijaya Padma V: Neferine and isoliensinine enhance ‘intracellular uptake of cisplatin’ and induce ‘ROS-mediated apoptosis’ in colorectal cancer cells-A comparative study. Food Chem Toxicol. 132:1106522019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shu G, Yue L, Zhao W, Xu C, Yang J, Wang S and Yang X: Isoliensinine, a bioactive alkaloid derived from embryos of nelumbo nucifera, induces hepatocellular carcinoma cell apoptosis through suppression of NF-κB signaling. J Agric Food Chem. 63:8793–8803. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Law BY, Chan WK, Xu SW, Wang JR, Bai LP, Liu L and Wong VK: Natural small-molecule enhancers of autophagy induce autophagic cell death in apoptosis-defective cells. Sci Rep. 4:55102014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang X, Wang X, Wu T, Li B, Liu T, Wang R, Liu Q, Liu Z, Gong Y and Shao C: Isoliensinine induces apoptosis in triple-negative human breast cancer cells through ROS generation and p38 MAPK/JNK activation. Sci Rep. 5:125792015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Baydoun HH, Pancewicz J, Bai X and Nicot C: HTLV–I p30 inhibits multiple S phase entry checkpoints, decreases cyclin E-CDK2 interactions and delays cell cycle progression. Mol Cancer. 9:3022010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang C, Xu B, Lu S, Zhao Y and Liu P: HN1 contributes to migration, invasion, and tumorigenesis of breast cancer by enhancing MYC activity. Mol Cancer. 16:902017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kong R, Zhang EB, Yin DD, You LH, Xu TP, Chen WM, Xia R, Wan L, Sun M, Wang ZX, et al: Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16. Mol Cancer. 14:822015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xin X, Wu M, Meng Q, Wang C, Lu Y, Yang Y, Li X, Zheng Q, Pu H, Gui X, et al: Long noncoding RNA HULC accelerates liver cancer by inhibiting PTEN via autophagy cooperation to miR15a. Mol Cancer. 17:942018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Weisner J, Landel I, Reintjes C, Uhlenbrock N, Trajkovic-Arsic M, Dienstbier N, Hardick J, Ladigan S, Lindemann M, Smith S, et al: Preclinical efficacy of covalent-allosteric AKT inhibitor borussertib in combination with trametinib in KRAS-Mutant pancreatic and colorectal cancer. Cancer Res. 79:2367–2378. 2019.PubMed/NCBI
|
|
25
|
Heerding DA, Rhodes N, Leber JD, Clark TJ, Keenan RM, Lafrance LV, Li M, Safonov IG, Takata DT, Venslavsky JW, et al: Identification of 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a novel inhibitor of AKT kinase. J Med Chem. 51:5663–5679. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Salony, Solé X, Alves CP, Dey-Guha I, Ritsma L, Boukhali M, Lee JH, Chowdhury J, Ross KN, Haas W, et al: AKT inhibition promotes nonautonomous cancer cell survival. Mol Cancer Ther. 15:142–153. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kadioglu O, Law BY, Mok SW, Xu SW, Efferth T and Wong VK: Mode of action analyses of neferine, a bisbenzylisoquinoline alkaloid of lotus (Nelumbo nucifera) against multidrug-resistant tumor cells. Front Pharmacol. 8:2382017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang T, Zhao C, Luo L, Zhao H, Cheng J and Xu F: The expression of Mcl-1 in human cervical cancer and its clinical significance. Med Oncol. 29:1985–1991. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cuconati A, Mukherjee C, Perez D and White E: DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells. Genes Dev. 17:2922–2932. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang Q, Yang M, Qu Z, Zhou J and Jiang Q: Autophagy prevention sensitizes AKTi-1/2-induced anti-hepatocellular carcinoma cell activity in vitro and in vivo. Biochem Biophys Res Commun. 480:334–340. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Correa RJ, Valdes YR, Peart TM, Fazio EN, Bertrand M, McGee J, Préfontaine M, Sugimoto A, DiMattia GE and Shepherd TG: Combination of AKT inhibition with autophagy blockade effectively reduces ascites-derived ovarian cancer cell viability. Carcinogenesis. 35:1951–1961. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fekete M, Santiskulvong C, Eng C and Dorigo O: Effect of PI3K/Akt pathway inhibition-mediated G1 arrest on chemosensitization in ovarian cancer cells. Anticancer Res. 32:445–452. 2012.PubMed/NCBI
|
|
33
|
de Frias M, Iglesias-Serret D, Cosialls AM, Coll-Mulet L, Santidrián AF, González-Gironès DM, de la Banda E, Pons G and Gil J: Akt inhibitors induce apoptosis in chronic lymphocytic leukemia cells. Haematologica. 94:1698–1707. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Prabhu KS, Siveen KS, Kuttikrishnan S, Jochebeth A, Ali TA, Elareer NR, Iskandarani A, Quaiyoom Khan A, Merhi M, Dermime S, et al: Greensporone A, a fungal secondary metabolite suppressed constitutively activated AKT via ROS generation and induced apoptosis in leukemic cell lines. Biomolecules. 9:1262019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Reddy D, Ghosh P and Kumavath R: Strophanthidin attenuates MAPK, PI3K/AKT/mTOR, and Wnt/β-catenin signaling pathways in human cancers. Front Oncol. 9:14692020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gilot D, Giudicelli F, Lagadic-Gossmann D and Fardel O: Akti-1/2, an allosteric inhibitor of Akt 1 and 2, efficiently inhibits CaMKIα activity and aryl hydrocarbon receptor pathway. Chem Biol Interact. 188:546–552. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cohen PA, Jhingran A, Oaknin A and Denny L: Cervical cancer. Lancet. 393:169–182. 2019. View Article : Google Scholar : PubMed/NCBI
|
